Filing Details
- Accession Number:
- 0001237899-10-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-07 12:00:00
- Reporting Period:
- 2010-01-06
- Filing Date:
- 2010-01-07
- Accepted Time:
- 2010-01-07 15:19:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226435 | A Murray Goldberg | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp F&A, Cfo, Treas & Asst Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-01-06 | 7,425 | $24.76 | 49,017 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-01-06 | 5,283 | $25.06 | 43,734 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,720 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold 7,425 shares of Company stock on Janurary 6, 2010 at prices ranging from $24.69 to $24.86. Upon request by the Commission staff, the Company, or a security holder of the Company, we will provide full information regarding the number of shares sold by the reporting person on Janurary 6, 2010 at each separate price.
- The reporting person sold 5,283 shares of Company stock on Janurary 6, 2010 at prices ranging from $25.01 to $25.12. Upon request by the Commission staff, the Company, or a security holder of the Company, we will provide full information regarding the number of shares sold by the reporting person on Janurary 6, 2010 at each separate price.
Billionaire Hedge Funds
